PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Sierra Oncology Reports NDA Submission of Momelotinib to the US FDA for the Treatment of Myelofibrosis

Sierra Oncology Reports NDA Submission of Momelotinib to the US FDA for the Treatment of Myelofibrosis

June 17, 2022

PharmaShots Weekly Snapshots (June 13– 17, 2022)

PharmaShots Weekly Snapshots (June 13– 17, 2022)

June 17, 2022

Basilea and Pfizer Collaborated to Commercialize Cresemba for Invasive Aspergillosis and Mucormycosis

Basilea and Pfizer Collaborated to Commercialize Cresemba for Invasive Aspergillosis and Mucormycosis

June 17, 2022

Addex Discontinue P-IIb/III Study of Dipraglurant for the Treatment of Dyskinesia Associated With Parkinson’s Disease

Addex Discontinue P-IIb/III Study of Dipraglurant for the Treatment of Dyskinesia Associated With Parkinson’s Disease

June 17, 2022

Cordis’ Radianz Radial Peripheral System Used in First-in-Human Procedure for Vascular Disease

Cordis’ Radianz Radial Peripheral System Used in First-in-Human Procedure for Vascular Disease

June 17, 2022

Checkpoint Therapeutics Reports Interim Results of Cosibelimab in Registration-Enabling Trial for Locally Advanced Cutaneous Squamous Cell Carcinoma

Checkpoint Therapeutics Reports Interim Results of Cosibelimab in Registration-Enabling Trial for Locally Advanced Cutaneous Squam...

June 17, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us